Pegvisomant therapy in acromegalic patient resistant to other treatment: case report

• Egile Nagusiak: Emilia Nowicka (Egilea), Michał Obel (Egilea), Piotr Dzikowski (Egilea), Martyna Stefaniak (Egilea), Zofia Pietrzak (Egilea), Ewa Obel (Egilea)
• Formatua: Liburua
• Argitaratua: Kazimierz Wielki University, 2022-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: Acromegaly is a chronic, rare disorder resulting from growth hormone (GH) hypersecretion, usually caused by a pituitary adenoma. GH stimulates synthesis of insulin-like growth factor 1 (IGF-1), whom assay should be used as a screening test whenever acromegaly is suspected. Patients wit...